Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells.

about

Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells.

Item

http://www.wikidata.org/entity/Q47218594

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells.

@en

Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells.

@nl

type

Item

label

Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells.

@en

Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells.

@nl

prefLabel

Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells.

@en

Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells.

@nl

P1476

Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells.

@en

P2093

Benedetta Lucani

http://www.w3.org/2001/XMLSchema#string

Catherine Pellat-Deceunynck

http://www.w3.org/2001/XMLSchema#string

Géraldine Descamps

http://www.w3.org/2001/XMLSchema#string

Hanane Djamai

http://www.w3.org/2001/XMLSchema#string

Martine Amiot

http://www.w3.org/2001/XMLSchema#string

Pierre-Samuel Gillardin

http://www.w3.org/2001/XMLSchema#string

Sophie Maiga

http://www.w3.org/2001/XMLSchema#string

Steven Le Gouill

http://www.w3.org/2001/XMLSchema#string

P2860

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines

RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53abnormal myeloma cells independently of the p53 pathway.

p63 and p73: roles in development and tumor formation.

Regulation of p73 activity by post-translational modifications.

p53 and E2f: partners in life and death.

PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylation.

p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach?

Targeting p73 in cancer.

P31

scholarly article

P356

10.3390/IJMS19010040

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29295500

http://www.w3.org/2001/XMLSchema#string

P932

5795990

http://www.w3.org/2001/XMLSchema#string